27
total announcements
VENUSREM.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹2,132 Cr
P/E (TTM)
18.3
EPS (TTM)
₹86.91
52W Low
₹432.10
52W High
₹2,044.30
Dividend Yield
0.61%
Beta
0.33
Price / Book
3.2
Debt / Equity
1.9
Revenue (TTM)
₹811 Cr
Gross Margin
51.02%
Operating Margin
15.33%
Venus Remedies Limited
Venus Remedies Limited has secured five marketing authorisations across four key international markets, including Kazakhstan, Peru, Kuwait, and Argentina, expanding its international presence and access to its pharmaceutical portfolio.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding 'Social Media Communication regarding special window for re-lodgement of transfer requests' of physical shares.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the securities received for dematerialization during the quarter ended 30th September 2026.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding change in Corporate Identification Number (CIN) from L24232CH1989PLC009705 to L21002CH1989PLC009705, following alteration to the Memorandum of Association.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange about the newspaper publication of notice to physical shareholders for transfer of physical shares as per SEBI circular.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange about newspaper publication of notice to physical shareholders for transfer of physical shares as per SEBI circular.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding a social media post on awareness about the transfer of physical shares.
Venus Remedies Limited
Venus Remedies Limited held its 37th Annual General Meeting (AGM) on August 20, 2026, through video conferencing. The meeting was attended by shareholders, and the voting results were as follows: all resolutions were passed with the requisite majority. The Scrutinizer's report dated August 21, 2026, was also enclosed.
Venus Remedies Limited
Venus Remedies Limited has submitted the Srutinizers report of the Annual General Meeting held on August 20, 2026, and informed the Exchange regarding voting results.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, primarily to align the Object Clause with the provisions of the Companies Act, 2013 and to update and suitably align the Main Objects and Objects Incidental or Ancillary to the Attainment Of the Main Objects with the Company's current business practices and proposed business activities.
Venus Remedies Limited
Venus Remedies Limited has announced the appointment of Dr. (Mrs.) Savita Gupta as Non-Executive Independent Director for a period of 5 years, effective from December 30, 2026. The company has also re-appointed Dr. (Mrs.) Manu Chaudhary as Joint Managing Director for a period of 5 years, effective from October 1, 2026, and appointed Mr. Saransh Chaudhary as Executive Director for a period of 5 years, effective from May 26, 2026.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding the appointment of Dr. Gurminder Singh Bedi as Non-Executive Independent Director and the re-appointment of Dr. (Mrs.) Manu Chaudhary as Joint Managing Director, Dr. (Mrs.) Savita Gupta as Non-Executive Independent Director, and Mr. Saransh Chaudhary as Executive Director.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding the appointment of Dr. (Mrs.) Manu Chaudhary as Joint Managing Director of the company, effective October 1, 2026. The company has also announced the appointment of Mr. Saransh Chaudhary as an Executive Director and Dr. Gurminder Singh Bedi as a Non-Executive Independent Director, both for a period of 5 years.
Venus Remedies Limited
Venus Remedies Limited has appointed Mr. Saransh Chaudhary as Executive Director, Dr. Gurminder Singh Bedi as Non-Executive Independent Director, re-appointed Dr. (Mrs.) Manu Chaudhary as Joint Managing Director, and re-appointed Dr. (Mrs.) Savita Gupta as Non-Executive Independent Director.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 20, 2026
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange about a social media post for awareness on transfer of shares, as per Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange about Copy of Newspaper Publication of 37th AGM Notice.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 20, 2026, Annual report 2025-26 is also enclosed herewith.
Venus Remedies Limited
Venus Remedies Limited has informed the Exchange about a copy of newspaper publication.